What are the NICE treatment guidelines for Charcot arthropathy?

Updated: Mar 23, 2020
  • Author: Mrugeshkumar Shah, MD, MPH, MS; Chief Editor: Vinod K Panchbhavi, MD, FACS, FAOA, FABOS, FAAOS  more...
  • Print

If the multidisciplinary foot care service suspects acute Charcot arthropathy, treatment with a nonremovable offloading device should be offered. If the use of such a device is inadvisable because of clinical or patient circumstances, treatment with a removable offloading device should be considered.

The use of bisphosphonates to treat acute Charcot arthropathy is not warranted, unless as part of a clinical trial.

Treatment of acute Charcot arthropathy should be monitored via clinical assessment, to include measurement of foot-skin temperature difference and serial radiographs until the acute Charcot arthropathy resolves. Resolution is likely when there is a sustained temperature difference of less than 2º between the two feet and when radiographic changes show no further progression.

People who have a foot deformity that may be the result of a previous Charcot arthropathy are at high risk of ulceration and should be cared for by the foot protection service.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!